Connection
Nahed El-Hassan to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Nahed El-Hassan has written about Antibodies, Monoclonal, Humanized.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.111 |
|
|
|
-
Elhassan NO, Sorbero ME, Hall CB, Stevens TP, Dick AW. Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease. Arch Pediatr Adolesc Med. 2006 Oct; 160(10):1070-6.
Score: 0.061
-
Elhassan NO, Stevens TP, Sorbero ME, Dick AW, Guillet R, Hall CB. Guidelines for palivizumab prophylaxis: are they based on infant's risk of hospitalization for respiratory syncytial viral disease? Pediatr Infect Dis J. 2003 Nov; 22(11):939-43.
Score: 0.050